HF
SQZ

HRT Financial’s SQZ Biotechnologies Company SQZ Stock Holding History

HRT Financial’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,987
Closed -$9K – 3471
2022
Q4 		$9K Buy
+12,987
New +$28.4K ﹤0.01% 2234
2021
Q1 		– Sell
-17,456
Closed -$505K – 3300
2020
Q4 		$505K Buy
+17,456
New +$446K 0.01% 1021

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's SQZ Position: Q1 2023 in Review

HRT Financial sold out of SQZ Biotechnologies Company (SQZ) in Q1 2023, closing a stake of 12,987 shares — an estimated $9K sold.

HRT Financial first reported a position in SQZ in Q4 2020 and held it in 2 quarters. The position peaked at $505K in Q4 2020. 32 funds tracked by Wall St. Rank hold SQZ as of Q1 2023.

  • HRT Financial reported no remaining SQZ Biotechnologies Company position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 12,987 SQZ Biotechnologies Company shares in Q1 2023, an estimated $9K.
  • HRT Financial first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 2 quarters.
  • HRT Financial's SQZ Biotechnologies Company position peaked at $505K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.